FDA Approves Non-Opioid Injectable Painkiller

January 21, 2015

Food and Drug Administration (FDA) recently approved (PDF) DylojectTM Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics.

Food and Drug Administration (FDA)

recently approved

(PDF) Dyloject

TM

Injection, a proprietary nonsteroidal anti-inflammatory drug meant for adults to manage mild to moderate pain and moderate to severe pain alone or in combination with opioid analgesics,

reports

the drug’s manufacturer, Hospira, Inc. The drug is an injectable therapy that can be administered in 15 seconds. It comes at a time when federal and local governments are working to reduce abuse of prescription opioid medications, with related deaths climbing to 16,500 in 2010, reports

Reuters

.